INOVIO Aktie

>INOVIO Aktienkurs

2.02 EUR +0.0% (Tradegate)

Ask: 1.96 EUR / 900 Stück

Bid: 1.91 EUR / 900 Stück

Tagesumsatz: 5477 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

INOVIO Aktie über LYNX handeln

Intraday

1 Jahr

>INOVIO Performance

1 Woche: +15,1%

1 Monat: +29,5%

3 Monate: +3,6%

6 Monate: +23,2%

1 Jahr: +12,2%

laufendes Jahr: +11,6%

>INOVIO Aktie

Name:

INOVIO PHARMACEUTICAL INC

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US45773H4092 / A400EJ

Symbol/ Ticker:

GBM (Frankfurt) / INO (NASDAQ)

Kürzel:

FRA:GBM, ETR:GBM, GBM:GR, NASDAQ:INO

Index:

Webseite:

https://inovio.com/

Profil:

Inovio Pharmaceuticals, Inc. is a biotechnology co..
>Volltext..

Marktkapitalisierung:

139.03 Mio. EUR

Unternehmenswert:

104.25 Mio. EUR

Umsatz:

0.16 Mio. EUR

EBITDA:

-74.03 Mio. EUR

Nettogewinn:

-92.3 Mio. EUR

Gewinn je Aktie:

-2.21 EUR

Schulden:

8.56 Mio. EUR

Liquide Mittel:

31.22 Mio. EUR

Operativer Cashflow:

-75.93 Mio. EUR

Bargeldquote:

0.73

Umsatzwachstum:

-14.95%

Gewinnwachstum:

9.14%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

INOVIO

Letzte Datenerhebung:

21.12.25

>INOVIO Kennzahlen

Aktien/ Unternehmen:

Aktien: 68.7 Mio. St.

Frei handelbar: 99.58%

Leerverk. Aktien: 12.56%

Rückkaufquote: -33.88%

Mitarbeiter: 134

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Buy

Kursziel: 224.88%

Bewertung:

KGV: -

KGV lG: -

KUV: 737.73

KBV: -

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -1551.12%

Gewinnmarge: -59281.69%

Operative Marge: -49202.88%

Managementeffizenz:

Gesamtkaprendite: -122.52%

Eigenkaprendite: -328.45%

>INOVIO Peer Group

Es sind 599 Aktien bekannt.

>INOVIO Chart & Kurs - NASDAQ

>INOVIO News

19.12.25 - 22:12	INOVIO Reports Inducement Grant Under Inducement Plan (PR Newswire)
	PLYMOUTH MEETING, Pa., Dec. 19, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made an......

18.11.25 - 14:09	INOVIO to Participate in December Investor Conferences (PR Newswire)
	PLYMOUTH MEETING, Pa., Nov. 18, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate......

14.11.25 - 19:45	Inovio (INO) Upgraded to Buy: Here′s Why (Zacks)
	Inovio (INO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....

11.11.25 - 15:06	INOVIO-Aktie gibt nach: Kapitalerhöhung über 25 Mio. Dollar mit Abschlag platziert (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

11.11.25 - 14:48	INOVIO announces pricing of $25M public offering (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

11.11.25 - 14:42	INOVIO Announces Pricing of $25 Million Public Offering (PR Newswire)
	PLYMOUTH MEETING, Pa., Nov. 11, 2025 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced the......

11.11.25 - 07:39	Inovio Pharmaceuticals drops 6%, proposes equity offering (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

11.11.25 - 01:33	Inovio outlines mid-2026 launch for INO-3107 as BLA submission progresses (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

11.11.25 - 00:12	INOVIO Announces Proposed Public Offering (PR Newswire)
	PLYMOUTH MEETING, Pa., Nov. 10, 2025 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced......

10.11.25 - 23:36	Inovio: Innovationsfokus trotz Nettoverlust im dritten Quartal 2025 (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

10.11.25 - 23:33	Oropharyngeal Cancer Market to Register Steady CAGR Throughout Forecast Period (2025-2034) Amid Shifting Treatment Paradigms \| DelveInsight (PR Newswire)
	The oropharyngeal cancer market is anticipated to grow during the forecast period (2025–2034), driven by the launch of emerging therapies such as PDS Biotechnology's Versamune HPV, Inovio Pharmaceuticals and MedImmune's INO-3112/MEDI0457, Cue Biopharma's CUE-101, BioNTech's BNT113, and......

10.11.25 - 22:12	Inovio Pharmaceuticals GAAP EPS of -$0.87 misses by $0.45 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

10.11.25 - 22:06	INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights (PR Newswire)
	Completed rolling Biologics License Application (BLA) submission seeking accelerated approval for lead candidate INO-3107; requested priority review Expect to receive file acceptance by year end 2025 with potential PDUFA date in mid-2026 if request for priority review granted Commercial......

09.11.25 - 23:39	Inovio Pharmaceuticals Q3 2025 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

03.11.25 - 14:09	INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults (PR Newswire)
	Recurrent respiratory papillomatosis (RRP) is a rare HPV-related disease of the respiratory tract with significant unmet need INO-3107 previously received Orphan Drug and Breakthrough Therapy designations; BLA submitted under FDA's Accelerated Approval program Expect to receive file......

31.10.25 - 21:54	INOVIO Reports Inducement Grant Under Inducement Plan (PR Newswire)
	PLYMOUTH MEETING, Pa., Oct. 31, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made an equity......

27.10.25 - 13:09	INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 (PR Newswire)
	PLYMOUTH MEETING, Pa., Oct. 27, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious diseases, today announced that its third quarter......

23.10.25 - 22:09	INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference (PR Newswire)
	PLYMOUTH MEETING, Pa., Oct. 23, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will......

02.10.25 - 14:09	INOVIO Reports Inducement Grant Under Inducement Plan (PR Newswire)
	PLYMOUTH MEETING, Pa., Oct. 2, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made an equity......

25.09.25 - 14:09	INOVIO to Participate in Upcoming Scientific Conferences (PR Newswire)
	Several presentations to highlight key aspects of lead product candidate, INO-3107, as a potential treatment for Recurrent Respiratory Papillomatosis (RRP) Additional presentations focus on promise of next-generation DNA medicine technology, including the first preclinical data describing......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Das ist halt dann ein positives Loch - ein sogenannter Berg. - Hans Mayr

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram